Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgery

American Journal of Physiology. Endocrinology and Metabolism
Maria S SvaneSten Madsbad

Abstract

Exaggerated secretion of glucagon-like peptide 1 (GLP-1) is important for postprandial glucose tolerance after Roux-en-Y gastric bypass (RYGB), whereas the role of glucose-dependent insulinotropic polypeptide (GIP) remains to be resolved. We aimed to explore the relative importance of endogenously secreted GLP-1 and GIP on glucose tolerance and β-cell function after RYGB. We used DPP-4 inhibition to enhance concentrations of intact GIP and GLP-1 and the GLP-1 receptor antagonist exendin-(9-39) (Ex-9) for specific blockage of GLP-1 actions. Twelve glucose-tolerant patients were studied after RYGB in a randomized, placebo-controlled, 4-day crossover study with standard mixed-meal tests and concurrent administration of placebo, oral sitagliptin, Ex-9 infusion, or combined Ex-9-sitagliptin. GLP-1 receptor antagonism increased glucose excursions, clearly attenuated β-cell function, and aggravated postprandial hyperglucagonemia compared with placebo, whereas sitagliptin had no effect despite two- to threefold increased concentrations of intact GLP-1 and GIP. Similarly, sitagliptin did not affect glucose tolerance or β-cell function during GLP-1R blockage. This study confirms the importance of GLP-1 for glucose tolerance after RYGB vi...Continue Reading

References

Jan 1, 1986·Diabetologia·M NauckW Creutzfeldt
Aug 1, 1986·The Journal of Clinical Endocrinology and Metabolism·M A NauckW Creutzfeldt
Aug 1, 1996·Computer Methods and Programs in Biomedicine·R HovorkaM A Young
Jan 14, 2003·Metabolism: Clinical and Experimental·Tadashi NagakuraIsao Tanaka
Oct 16, 2007·Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery·Judith KornerJens Juul Holst
Mar 11, 2009·The American Journal of Medicine·Henry BuchwaldIsabella Sledge
Nov 7, 2009·The Journal of Clinical Endocrinology and Metabolism·Adam M DeaneMichael Horowitz
Dec 10, 2009·American Journal of Physiology. Endocrinology and Metabolism·Meena AsmarJens Juul Holst
Dec 24, 2009·International Journal of Obesity : Journal of the International Association for the Study of Obesity·S R KashyapP R Schauer
Nov 5, 2010·The Journal of Clinical Endocrinology and Metabolism·Mathias NicolausJörg Schirra
May 20, 2011·The Journal of Clinical Endocrinology and Metabolism·Ola LindgrenBo Ahrén
May 20, 2011·The Journal of Clinical Endocrinology and Metabolism·Melissa A ReedG Lynis Dohm
Apr 27, 2012·American Journal of Physiology. Endocrinology and Metabolism·N B JørgensenJ J Holst
Jan 31, 2013·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·C DirksenJ L Madsen
Apr 1, 2014·The New England Journal of Medicine·Philip R SchauerUNKNOWN STAMPEDE Investigators

❮ Previous
Next ❯

Citations

Jul 20, 2016·International Journal of Obesity : Journal of the International Association for the Study of Obesity·M S SvaneJ J Holst
Dec 4, 2016·Annual Review of Physiology·Simon S EversRandy J Seeley
Oct 27, 2017·Diabetes, Obesity & Metabolism·Ankit ShahBlandine Laferrère
Feb 17, 2017·Physiological Reports·Signe NielsenKirstine N Bojsen-Moller
Mar 19, 2019·Journal of Neuroendocrinology·Darleen A Sandoval
Jan 25, 2018·Diabetes, Obesity & Metabolism·Michael A Nauck, Juris J Meier
May 31, 2019·Diabetes, Obesity & Metabolism·Caroline Christfort ØhrstrømDorte Lindqvist Hansen
Aug 21, 2020·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·Daniela Rosendo-Silva, Paulo Matafome
Sep 6, 2018·Nature Reviews. Gastroenterology & Hepatology·Piriyah SinclairCarel W le Roux
Oct 19, 2017·Endocrinology·Chelsea R Hutch, Darleen Sandoval
Oct 15, 2019·Frontiers in Endocrinology·Isabel Cornejo-ParejaFrancisco J Tinahones
Feb 23, 2020·The Journal of Clinical Endocrinology and Metabolism·Lærke S GasbjergFilip K Knop
Nov 21, 2020·Annual Review of Medicine·Nastazja Dagny PilonisMassimiliano di Pietro
Mar 4, 2021·Nutrients·Dimitris Papamargaritis, Carel W le Roux
Mar 27, 2021·Current Opinion in Gastroenterology·Keri A Seymour, Manal F Abdelmalek
Mar 28, 2021·Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery·Morten HindsøKirstine N Bojsen-Møller
Jun 5, 2021·The Journal of Clinical Endocrinology and Metabolism·Kristina E AlmbyJan W Eriksson
Aug 12, 2021·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·Maria S SvaneSimon Veedfald
Aug 6, 2021·Diabetes, Obesity & Metabolism·Laerke Smidt GasbjergFilip Krag Knop
Jul 27, 2021·Diabetes, Obesity & Metabolism·Michael A NauckAndreas F H Pfeiffer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.